Annual Total Liabilities
$250.81 M
-$33.72 M-11.85%
December 31, 2023
Summary
- As of February 8, 2025, NTLA annual total liabilities is $250.81 million, with the most recent change of -$33.72 million (-11.85%) on December 31, 2023.
- During the last 3 years, NTLA annual total liabilities has risen by +$101.56 million (+68.05%).
- NTLA annual total liabilities is now -11.85% below its all-time high of $284.53 million, reached on December 31, 2022.
Performance
NTLA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$210.74 M
-$9.74 M-4.42%
September 30, 2024
Summary
- As of February 8, 2025, NTLA quarterly total liabilities is $210.74 million, with the most recent change of -$9.74 million (-4.42%) on September 30, 2024.
- Over the past year, NTLA quarterly total liabilities has increased by +$4.80 million (+2.33%).
- NTLA quarterly total liabilities is now -25.94% below its all-time high of $284.53 million, reached on December 31, 2022.
Performance
NTLA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NTLA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.8% | +2.3% |
| 3 y3 years | +68.0% | -7.5% |
| 5 y5 years | +261.4% | +196.9% |
NTLA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.8% | at low | -25.9% | +2.3% |
| 5 y | 5-year | -11.8% | +289.5% | -25.9% | +227.2% |
| alltime | all time | -11.8% | +7918.2% | -25.9% | +263.6% |
Intellia Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $210.74 M(-4.4%) |
| Jun 2024 | - | $220.47 M(-1.3%) |
| Mar 2024 | - | $223.45 M(-10.9%) |
| Dec 2023 | $250.81 M(-11.9%) | $250.81 M(+21.8%) |
| Sep 2023 | - | $205.94 M(-5.7%) |
| Jun 2023 | - | $218.35 M(-3.8%) |
| Mar 2023 | - | $227.05 M(-20.2%) |
| Dec 2022 | $284.53 M(+11.9%) | $284.53 M(+9.6%) |
| Sep 2022 | - | $259.51 M(+12.9%) |
| Jun 2022 | - | $229.88 M(-7.7%) |
| Mar 2022 | - | $249.03 M(-2.0%) |
| Dec 2021 | $254.22 M(+70.3%) | $254.22 M(+11.6%) |
| Sep 2021 | - | $227.86 M(+28.4%) |
| Jun 2021 | - | $177.43 M(+3.7%) |
| Mar 2021 | - | $171.02 M(+14.6%) |
| Dec 2020 | $149.25 M | $149.25 M(+15.8%) |
| Sep 2020 | - | $128.94 M(-7.4%) |
| Jun 2020 | - | $139.24 M(+107.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $66.99 M(+4.0%) |
| Dec 2019 | $64.40 M(-7.2%) | $64.40 M(-9.3%) |
| Sep 2019 | - | $70.98 M(-6.1%) |
| Jun 2019 | - | $75.58 M(-5.6%) |
| Mar 2019 | - | $80.03 M(+15.3%) |
| Dec 2018 | $69.39 M(-8.3%) | $69.39 M(+19.7%) |
| Sep 2018 | - | $57.96 M(-4.1%) |
| Jun 2018 | - | $60.44 M(-5.6%) |
| Mar 2018 | - | $64.05 M(-15.3%) |
| Dec 2017 | $75.64 M(-15.1%) | $75.64 M(+3.2%) |
| Sep 2017 | - | $73.32 M(-5.3%) |
| Jun 2017 | - | $77.39 M(-2.5%) |
| Mar 2017 | - | $79.38 M(-10.9%) |
| Dec 2016 | $89.13 M(-13.7%) | $89.13 M(+6.9%) |
| Sep 2016 | - | $83.34 M(-4.2%) |
| Jun 2016 | - | $87.02 M(-15.3%) |
| Mar 2016 | - | $102.68 M(-0.6%) |
| Dec 2015 | $103.34 M(+3203.7%) | $103.34 M |
| Dec 2014 | $3.13 M | - |
FAQ
- What is Intellia Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Intellia Therapeutics?
- What is Intellia Therapeutics annual total liabilities year-on-year change?
- What is Intellia Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly total liabilities year-on-year change?
What is Intellia Therapeutics annual total liabilities?
The current annual total liabilities of NTLA is $250.81 M
What is the all time high annual total liabilities for Intellia Therapeutics?
Intellia Therapeutics all-time high annual total liabilities is $284.53 M
What is Intellia Therapeutics annual total liabilities year-on-year change?
Over the past year, NTLA annual total liabilities has changed by -$33.72 M (-11.85%)
What is Intellia Therapeutics quarterly total liabilities?
The current quarterly total liabilities of NTLA is $210.74 M
What is the all time high quarterly total liabilities for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly total liabilities is $284.53 M
What is Intellia Therapeutics quarterly total liabilities year-on-year change?
Over the past year, NTLA quarterly total liabilities has changed by +$4.80 M (+2.33%)